{
  "ptid_time": "023_S_0376_2010-05-14",
  "img_path": "/data/qiuhui/data/adni/images/023_S_0376/2010-05-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 79,562 mm³, 106.6% above the reference mean. With a Z-score of 2.55 (99.5th percentile), this represents significant enlargement; hippocampal volume measures 5,937 mm³, 21.5% below the reference mean. With a Z-score of -2.09 (1.8th percentile), this represents significant atrophy; whole brain volume measures 912,442 mm³, 15.5% below the reference mean. With a Z-score of -2.01 (2.2th percentile), this represents significant atrophy; entorhinal cortex volume measures 3,809 mm³, 7.1% below the reference mean. With a Z-score of -0.48 (31.5th percentile), this represents normal volume ; fusiform gyrus volume measures 16,491 mm³, 12.5% below the reference mean. With a Z-score of -1.06 (14.4th percentile), this represents mild atrophy; middle temporal gyrus volume measures 18,603 mm³, 12.8% below the reference mean. With a Z-score of -1.15 (12.5th percentile), this represents mild atrophy. ",
  "text_data": "Age is 74.5 years. Gender is Male. Education: 15 years. Handedness: Right. Race: White. Medical history: Hepatic; Dermatologic-Connective Tissue; Musculoskeletal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 28.0. MoCA: 21.0. Logical Memory: 5.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.90 SUVR (mild reduced); Amyloid beta: 1492.00 pg/mL (mild elevated); Total tau: 185.40 pg/mL (normal ); Phosphorylated tau: 13.32 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal and whole brain atrophy, along with ventricular enlargement, which are strong indicators of neurodegeneration. The MoCA score of 21 (below the typical cutoff of 26) suggests cognitive impairment, while the MMSE of 28 is still within the normal range, indicating possible early-stage decline. The biomarker profile (mildly elevated Aβ, normal T-tau, and mildly reduced P-tau) does not strongly support Alzheimer’s pathology but does not rule it out.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting biomarker results and the relatively preserved MMSE score despite MoCA impairment)",
  "timestamp": "2025-07-26T02:42:25.033044"
}